Navigation Links
Gene Therapy May Treat Erectile Dysfunction
Date:5/20/2008

Studies in both men and monkeys show effectiveness of treatment

TUESDAY, May 20 (HealthDay News) -- Gene therapy may be a way to treat erectile dysfunction in men who do not respond to pills such as Viagra, researchers report.

Maxi-K gene therapy is a gene transfer that improves erectile dysfunction. Two studies using the gene were presented Tuesday at the American Urological Association's annual meeting, in Orlando, Fla.

"Gene transfer technology has the potential for long-term improvement for erectile function," lead researcher Dr. Arnold Melman, a professor of medicine at Albert Einstein College of Medicine in New York City, said during a morning teleconference Tuesday.

"The market for erectile dysfunction is quite large," Melman said. "And medications such as Viagra don't work very well in 40 percent of men."

Melman noted that a recent survey showed that 50 percent of urologists would consider switching their patients from their current medications to gene transfer treatment. "So, we think this will be well-accepted by physicians and patients," he said.

Results of a phase I trial testing gene transfer in 11 men with erectile dysfunction who had failed other therapy showed that gene transfer was safe and also had restorative effects. Four different doses were tried during the trial. Men receiving the highest dose showed improvement for up to six months, Melman said.

"These men had normal sexual function for six months and then went back to the way they were," Melman said. He added that two doses a year would be enough for most men to maintain their normal sexual function.

During two years of follow-up, none of the men reported any abnormalities after the gene transfer. The procedure was safe, and no adverse effects were seen, Melman said.

Based on these findings, Melman's group is moving on to new trials and hopes to have a product on the market within two years.

In another trial, four monkeys were fed a high-fat diet, which reduced their sex drive. After the monkeys received a Maxi-K gene transfer, they became friskier.

In addition, the number of partial and full erections increased about fivefold, the researchers found. Also, the frequency of ejaculations increased among the monkeys that received the gene transfer. Moreover, the gene transfer affected how the monkeys behaved with female monkeys.

"The most fascinating thing is there was the increased socialization," lead researcher George J. Christ, a professor of urology and head of the Program in Cell Tissue and Organ Physiology at the Wake Forest Institute for Regenerative Medicine, said during Tuesday's teleconference. "After receiving a gene transfer and regaining sexual function, they felt better about themselves."

More information

For more on erectile dysfunction, visit the National Institute of Diabetes and Digestive and Kidney Diseases.



SOURCES: May 20, 2008, teleconference with Arnold Melman, M.D., professor, medicine, Albert Einstein College of Medicine, New York City; George J. Christ, Ph.D., professor, urology, and head, Program in Cell, Tissue and Organ Physiology, Wake Forest Institute for Regenerative Medicine, Winston-Salem, N.C., May 20, 2008, presentations, American Urological Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Invasive methods unnecessary for prostate cancer radiation therapy treatment planning
2. A potential route for human tumor gene therapy
3. New patient satisfaction study with budesonide/formoterol combination therapy
4. Hormone Therapy Safe, Effective for Women Entering Menopause
5. Self Help Therapy for Veterans with Traumatic Brain Injury (TBI)
6. Personalized therapy for asthma and COPD could soon be here
7. Not All Colon Cancer Patients Need Chemotherapy: Study
8. New Therapy Kills Human Leukemia Cells in Mice
9. Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
10. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
11. Adding epratuzumab to standard therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Therapy May Treat Erectile Dysfunction
(Date:1/23/2017)... ... January 23, 2017 , ... The American Academy of ... scientific development, healthcare training and clinical application of medical infrared imaging, has announced ... Certification Qualification Courses for Technicians, respectively. , For the first time the AAT ...
(Date:1/23/2017)... Switzerland (PRWEB) , ... January 23, 2017 , ... ... lab and production applications. However, choosing the right method is paramount to success. ... occur more often in situations where multiple persons use the same equipment. Rare ...
(Date:1/23/2017)... ... ... Old School Labs™, makers of the wildly popular all-natural sports supplements based ... its growing team of brand ambassadors. The Olympia top finisher and former Big 12 ... year was able to turn professional, participating in the 2013 NPC USA Championships in ...
(Date:1/23/2017)... ... ... a story of love and redemption, hope and uncertainty as a girl makes her ... Inn at the Mill” is the creation of published author, Lois Kulp, who was born ... Berks County on Crow Hill. The inn, the mill and "Post Yokel" are ...
(Date:1/23/2017)... ... ... “Life Under Blankets”: an entrancing story about one woman's travels through the ... creation of published author, Kimberly Mitchell, who earned her bachelor’s degree in English education ... a master’s degree in education in the field of curriculum and instruction. Kimberly’s passion ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... SAN DIEGO and PALMA, ... Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical ... announced that the first patient has been enrolled ... of lead candidate, SNF472, for the treatment of ... haemodialysis (HD). Most ESRD patients, in ...
(Date:1/21/2017)... 20, 2017 Research and Markets has ... Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), ... of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" ... ... healthcare services, market segments, especially clinical lab testing, which has ...
(Date:1/21/2017)... Jan 20, 2017 Research and Markets has ... & Trends - Technology, Route Of Administration, End User - Forecast ... ... poised to grow at a CAGR of around 7.8% over the ... This industry report analyzes the global markets for Advanced Drug ...
Breaking Medicine Technology: